Vietnam says Pfizer and MSD to grant its firms licenses to produce Covid-19 pills


South Korean tourists arrive at a hotel in Phu Quoc island, among the first wave of visitors in nearly two years as the country seeks to resurrect its pandemic-ravaged tourism economy, in Vietnam, November 20, 2021. - Reuters

HANOI, Nov 26 (Reuters): Drugmakers Pfizer Inc and MSD, known as Merck & Co Inc in North America, have agreed to give licenses to firms in Vietnam to produce Covid-19 treatment pills, Vietnam's ministry of health said on Friday.

The companies have sent letters of approval to the Drug Administration of Vietnam, the ministry said in a statement, for the production of Molnupiravir and Paxlovid pills.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Vietnam , Pfizer , MSD

   

Next In Aseanplus News

Rahul to stand in Raebareli too
US: Ship damage, injury to crew is ‘irresponsible behaviour’
Safer streets with Seoul’s paw patrol
‘Pyongyang plotting attacks’
Orangutan seen apparently treating wound
Men banned from working abroad
Assembly accepts chairman’s resignation
Heatwave swells Asia’s appetite for air-cons
Probe to collect samples from far side of Moon
WSJ to move Asia HQ from Hong Kong to Singapore

Others Also Read